Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention
BALTIMORE, MD, JUNE 9, 2011 — Paragon Bioservices, Inc., a Baltimore-based contract research and GMP manufacturing organization, announced today that representatives from the company will be participating in the 2011 BIO International Convention’s One-on-One Partnering Meetings being held on June 27-30 in Washington, D.C. at the Walter E. Washington Convention Center.
Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies. With a focus on vaccines (VLPs), monoclonal antibodies, therapeutic proteins and stem cells, Paragon’s role is to bridge the translational divide and to enable vaccines—as well as proteins and cell-based therapeutics—to move from the research bench into Phase I/II clinical trials.
Representatives available to discuss Paragon’s capabilities include: Dr. Marco Chacón, President & CEO; Jessica Boehmer, Director of Sales & Business Development; Dr. Philip Wills, Corporate Scientific Liaison; and Dr. Aaron Heifetz, Stem Cell & Regenerative Medicine.
For companies or individuals not participating in partnering meetings, Paragon will be exhibiting in booth number 1657 located in Hall A – BIO Process Zone.
ABOUT PARAGON BIOSERVICES, INC.
Located in Baltimore, Maryland, Paragon Bioservices is a privately held contract research and manufacturing organization (CMO) with a focus on the development and manufacturing of biopharmaceuticals—either for research purposes or clinical trials. Working as an outsourcing partner and with a long standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and government agencies involved in the development of monoclonal antibodies, therapeutic proteins, vaccines/VLPs and stem cells.
Tiberend Strategic Advisors, Inc.
Tamara Bright or Claire Sojda